Page 1 | Search Results | Cancer Epidemiology, Biomarkers & Prevention

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Designing Rigorous and Efficient Clinical Utility Studies for Early Detection Biomarkers

Yingye Zheng, Paul D. Wagner, Amit G. Singal, Samir M. Hanash, Sudhir Srivastava, Ying Huang, Ying-Qi Zhao, Suresh T. Chari, Guillermo Marquez, Ruth Etizioni, Tracey L. Marsh, Ziding Feng

Cancer Epidemiol Biomarkers Prev (2024) 33 (9): 1150–1157.

https://doi.org/10.1158/1055-9965.EPI-23-1594

Published: 03 September 2024

View articletitled, Designing Rigorous and Efficient Clinical Utility Studies for Early Detection Biomarkers

Journal Articles

The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers

Sudhir Srivastava, Paul D. Wagner

Cancer Epidemiol Biomarkers Prev (2020) 29 (12): 2401–2410.

https://doi.org/10.1158/1055-9965.EPI-20-0237

Published: 01 December 2020

View articletitled, The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers

Journal Articles

The National Cancer Institute Early Detection Research Network: Two Decades of Progress

Robert C. Bast, Jr, Sudhir Srivastava

Cancer Epidemiol Biomarkers Prev (2020) 29 (12): 2396–2400.

https://doi.org/10.1158/1055-9965.EPI-20-1158

Published: 01 December 2020

View articletitled, The National Cancer Institute Early Detection Research Network: Two Decades of Progress

Journal Articles

Abstract C023: Annexin A2 expression level correlates with adverse pathology and disease progression in prostate cancer

Shyh-Han Tan, Denise Young, Wei Huang, Amina Ali, Lakshmi Ravindranath, Kurt Christen, Kevin Babcock, Huai-Ching Kuo, Yongmei Chen, Jacob Kagan, Sudhir Srivastava, Albert Dobi, Srinivasan Alagarsamy, Gyorgy Petrovics, David G. McLeod, Jennifer Cullen, Inger L. Rosner, Isabell A. Sesterhenn, Shiv Srivastava

Cancer Epidemiol Biomarkers Prev (2020) 29 (6_Supplement_1): C023.

https://doi.org/10.1158/1538-7755.DISP18-C023

Published: 01 June 2020

View articletitled, Abstract C023: Annexin A2 expression level correlates with adverse pathology and disease progression in prostate cancer

Journal Articles

Abstract A111: Urine-based gene expression panels with focus on prostate cancer in African Americans

Indu Kohaar, Sreedatta Banerjee, Yongmei Chen, Amina Ali, Jacob Kagan, Sudhir Srivastava, Jennifer Cullen, Inger Rosner, Shiv Srivastava, Gyorgy Petrovics

Cancer Epidemiol Biomarkers Prev (2020) 29 (6_Supplement_1): A111.

https://doi.org/10.1158/1538-7755.DISP18-A111

Published: 01 June 2020

View articletitled, Abstract A111: Urine-based gene expression panels with focus on prostate cancer in African Americans

Journal Articles

GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score

Cancer Epidemiol Biomarkers Prev (2019) 28 (3): 531–538.

https://doi.org/10.1158/1055-9965.EPI-18-0281

Published: 04 March 2019

View articletitled, GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score

Includes: Supplementary data

Journal Articles

Abstract B57: Distinct genomic alterations in prostate cancer of African American men

Albert Dobi, Gyorgy Petrovics, Hua Li, Denise Young, Yongmei Chen, Jacob Kagan, Sudhir Srivastava, Reinhard Ebner, Inger L. Rosner, Jennifer Cullen, Matthew L. Freedman, Isabell A. Sesterhenn, Zoltan Szallasi, Shiv Srivastava

Cancer Epidemiol Biomarkers Prev (2018) 27 (7_Supplement): B57.

https://doi.org/10.1158/1538-7755.DISP17-B57

Published: 01 July 2018

View articletitled, Abstract B57: Distinct genomic alterations in prostate cancer of African American men

Journal Articles

Abstract B42: Development of a urine exosome-based prostate cancer gene expression panel to address racial differences in prostate cancer

Indu Kohaar, Sreedatta Banerjee, Lakshmi Ravindranath, Yongmei Chen, Amina Ali, Jacob Kagan, Sudhir Srivastava, Albert Dobi, David McLeod, Inger L. Rosner, Shiv Srivastava, Gyorgy Petrovics

Cancer Epidemiol Biomarkers Prev (2018) 27 (7_Supplement): B42.

https://doi.org/10.1158/1538-7755.DISP17-B42

Published: 01 July 2018

View articletitled, Abstract B42: Development of a urine exosome-based prostate cancer gene expression panel to address racial differences in prostate cancer

Journal Articles

Abstract PR01: Distinct genomic alterations in prostate cancer of African American men

Cancer Epidemiol Biomarkers Prev (2018) 27 (7_Supplement): PR01.

https://doi.org/10.1158/1538-7755.DISP17-PR01

Published: 01 July 2018

View articletitled, Abstract PR01: Distinct genomic alterations in prostate cancer of African American men

Journal Articles

Abstract C18: ERG-focused evaluations of prostate cancer of African American men and its potential impact on utility in biomarker development and in enhanced personalized medicine

Albert Dobi, Philip Rosen, James Farrell, Michael Degon, Denise Young, Sudhir Srivastava, Jacob Kagan, Gyorgy Petrovics, Jennifer Cullen, David G. McLeod, Isabell A. Sesterhenn, Shiv Srivastava

Cancer Epidemiol Biomarkers Prev (2014) 23 (11_Supplement): C18.

https://doi.org/10.1158/1538-7755.DISP13-C18

Published: 01 November 2014

View articletitled, Abstract C18: ERG-focused evaluations of prostate cancer of African American men and its potential impact on utility in biomarker development and in enhanced personalized medicine

Journal Articles

A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [−2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness

Lori J. Sokoll, Martin G. Sanda, Ziding Feng, Jacob Kagan, Isaac A. Mizrahi, Dennis L. Broyles, Alan W. Partin, Sudhir Srivastava, Ian M. Thompson, John T. Wei, Zhen Zhang, Daniel W. Chan

Cancer Epidemiol Biomarkers Prev (2010) 19 (5): 1193–1200.

https://doi.org/10.1158/1055-9965.EPI-10-0007

Published: 05 May 2010

View articletitled, A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [−2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness

Journal Articles

Joint National Cancer Institute-Food and Drug Administration Workshop on Research Strategies, Study Designs, and Statistical Approaches to Biomarker Validation for Cancer Diagnosis and Detection

Padma Maruvada, Sudhir Srivastava

Cancer Epidemiol Biomarkers Prev (2006) 15 (6): 1078–1082.

https://doi.org/10.1158/1055-9965.EPI-05-0432

Published: 14 June 2006

View articletitled, Joint National Cancer Institute-Food and Drug Administration Workshop on Research Strategies, Study Designs, and Statistical Approaches to Biomarker Validation for Cancer Diagnosis and Detection

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Designing Rigorous and Efficient Clinical Utility Studies for Early Detection Biomarkers

The Early Detection Research Network: A National Infrastructure to Support the Discovery, Development, and Validation of Cancer Biomarkers

The National Cancer Institute Early Detection Research Network: Two Decades of Progress

Abstract C023: Annexin A2 expression level correlates with adverse pathology and disease progression in prostate cancer

Abstract A111: Urine-based gene expression panels with focus on prostate cancer in African Americans

GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score

Abstract B57: Distinct genomic alterations in prostate cancer of African American men

Abstract B42: Development of a urine exosome-based prostate cancer gene expression panel to address racial differences in prostate cancer

Abstract PR01: Distinct genomic alterations in prostate cancer of African American men

Abstract C18: ERG-focused evaluations of prostate cancer of African American men and its potential impact on utility in biomarker development and in enhanced personalized medicine

A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [−2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness

Joint National Cancer Institute-Food and Drug Administration Workshop on Research Strategies, Study Designs, and Statistical Approaches to Biomarker Validation for Cancer Diagnosis and Detection

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only